Outstanding Agreements. The Vendor is not a party to or bound by any outstanding or executory agreement, contract or commitment, whether written or oral, relating to the Purchased Assets, except for those agreements set out in this Agreement or in the Schedules hereto. Complete and correct copies of each of the contracts, leases and agreements described in the Schedules attached hereto have been provided to the Purchaser.
Outstanding Agreements. The Corporation is not a party to or bound by any outstanding or executory agreement, contract or commitment, whether written or oral, except for:
Outstanding Agreements. Except in each case as set forth in a memorandum prepared by CN Pharma and previously furnished to Isodiol, as of the Effective Date neither CN Pharma nor any of its subsidiaries is a holder of or a party to any written or oral (i) contract for employment of any officer or other person other than its officers and Directors, (ii) contract with any labor union, (iii) bonus, pension, profit sharing, retirement, stock purchase, stock option, insurance, or similar plan or practice in effect with respect to its employees or other persons, (iv) indenture of mortgage, debenture, indenture, loan or borrowing agreement, (v) bonding arrangement, including performance bond, (vi) continuing contract for future purchase, sales, lease or distribution of materials, services, supplies, products, or equipment involving annual payments in excess of Five Thousand Canadian Dollars (CAD5,000.00), (vii) lease or other commitment for the rental of office space, storage or other facilities, (viii) contract or lease agreement for the acquisition or lease of motor vehicles, (ix) patent, patent application, patent right, patentable inventions, trademark, trademark registration and applications therefor, trade name, copyright, copyright registration and application therefor, patent license granted to or by CN Pharma or its subsidiaries and in force or contracts with employees or others relating in whole or in part to disclosure, assignment or patenting of any inventions, discoveries, improvements, shop rights, processes, formulae or other know-how, presently owned or held, in whole or in part, by CN Pharma or its subsidiaries, (x) insurance policy covering its properties, buildings machinery, equipment, and persons, firms or operations, or the life of any person, (xi) agreement between a present employee of CN Pharma and persons, firms, or corporations other than CN Pharma relating in whole or in art to disclosure, assignment or patenting of inventions, discoveries, improvements, shop rights, processes, formulae or other know- how, including without limitation thereto, to the best knowledge of CN Pharma, agreements entered into by such employees prior to the time they became employees of CN Pharma, or (xii) material contract or commitment not made in the ordinary course of business.
Outstanding Agreements. The Company has provided the Stockholders with copies of all outstanding agreements providing for the demand registration or piggyback registration of securities issued by the Company.
Outstanding Agreements. Except as set forth in Schedule 2.3, the Company is not a party to any material agreements.
Outstanding Agreements. There are no outstanding agreements to which BOLD is a party or any agreements contemplated by BOLD.
Outstanding Agreements. Except in each case as set forth in a memorandum prepared by NVPR and each Selling Member who may have a creditor claim, causes of action, or lien against NVPR or any of its assets and previously furnished to CMC, as of the Effective Date neither NVPR nor any of its subsidiaries is a holder of or a party to any written or oral (i) contract for employment of any officer or other person other than its officers and Directors, (ii) contract with any labor union, (iii) bonus, pension, profit sharing, retirement, stock purchase, stock option, insurance, or similar plan or practice in effect with respect to its employees or other persons, (iv) indenture of mortgage, debenture, indenture, loan or borrowing agreement, (v) bonding arrangement, including performance bond, (vi) continuing contract for future purchase, sales, lease or distribution of materials, services, supplies, products, or equipment involving annual payments in excess of Two Hundred Thousand U.S. Dollars (US$200,000), (vii) lease or other commitment for the rental of office space, storage or other facilities, (viii) contract or lease agreement for the acquisition or lease of motor vehicles, (ix) patent, patent application, patent right, patentable inventions, trademark, trademark registration and applications therefor, trade name, copyright, copyright registration and application therefor, patent license granted to or by NVPR or its subsidiaries and in force or contracts with employees or others relating in whole or in part to disclosure, assignment or patenting of any inventions, discoveries, improvements, shop rights, processes, formulae or other know-how, presently owned or held, in whole or in part, by NVPR or its subsidiaries, (x) insurance policy covering its properties, buildings machinery, equipment, and persons, firms or operations, or the life of any person, (xi) agreement between a present employee of NVPR and persons, firms, or corporations other than NVPR relating in whole or in art to disclosure, assignment or patenting of inventions, discoveries, improvements, shop rights, processes, formulae or other know-how, including without limitation thereto, to the best knowledge of NVPR, agreements entered into by such employees prior to the time they became employees of NVPR, or (xii) material contract or commitment not made in the ordinary course of business. Any creditor claim, cause of action, or lien, whether now existing or hereafter assertible against NVPR, that is not reflected in a m...
Outstanding Agreements. There are no outstanding agreements of sale, options or any other rights of third parties to acquire or use the Property or to any interest therein, except for the Permitted Exceptions. There are no contracts applicable to the Property that will survive Closing.
Outstanding Agreements. The Company and each Subsidiary has no obligation (contingent or otherwise) to pay any dividend or make any other distribution in respect of any of its capital stock. Except as set forth on Schedule 2.2(c) hereto, the Company and each Subsidiary is not a party to, and to the Company's knowledge there are no voting trusts or agreements, stockholders' agreements, pledge agreements, buy-sell agreements, rights of first refusal or proxies relating to any securities of the Company or any Subsidiary (whether or not the Company or any Subsidiary is a party thereto). All of the outstanding securities of the Company and each Subsidiary were issued in compliance with all applicable federal and state securities laws. Except as set forth in the certificate of incorporation for the Company and each Subsidiary or in this Agreement, the Company and each Subsidiary has no obligation (contingent or otherwise) to repurchase, redeem or otherwise acquire any shares of its capital stock, except as set forth in Section 2.2(b) hereof.
Outstanding Agreements. SELLER represents and warrants that the Premises are not the subject of any outstanding agreements with any party pursuant to which any such party may acquire any interest in the Premises, other than Seller’s Tenants and mortgagees.
